Kathleen Laporte - Net Worth and Insider Trading

Kathleen Laporte Net Worth

The estimated net worth of Kathleen Laporte is at least $804 dollars as of 2024-11-05. Kathleen Laporte is the Director of Bolt Biotherapeutics Inc and owns about 1,200 shares of Bolt Biotherapeutics Inc (BOLT) stock worth over $804. Kathleen Laporte is also the Director of 89bio Inc and owns about 0 shares of 89bio Inc (ETNB) stock worth over $0. Details can be seen in Kathleen Laporte's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kathleen Laporte has not made any transactions after 2023-07-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Kathleen Laporte

Kathleen Laporte Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kathleen Laporte owns 7 companies in total, including Precipio Inc (PRPO) , Affymax Inc (AFFY) , and Paratek Pharmaceuticals Inc (PRTK) among others .

Click here to see the complete history of Kathleen Laporte’s form 4 insider trades.

Insider Ownership Summary of Kathleen Laporte

Ticker	Comapny	Transaction Date	Type of Owner
PRPO	Precipio Inc	2018-08-07	director
AFFY	Affymax Inc	2012-12-14	director
PRTK	Paratek Pharmaceuticals Inc	2010-01-14	director
		2006-10-12	director
		2022-03-24	director
		2023-07-17	director
		2021-10-05	director

Kathleen Laporte Latest Holdings Summary

Kathleen Laporte currently owns a total of 2 stocks. Among these stocks, Kathleen Laporte owns 1,200 shares of Bolt Biotherapeutics Inc (BOLT) as of February 9, 2021, with a value of $804 and a weighting of 100%. Kathleen Laporte also owns 0 shares of 89bio Inc (ETNB) as of July 17, 2023, with a value of $0 and a weighting of 0%.

Latest Holdings of Kathleen Laporte

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
BOLT	Bolt Biotherapeutics Inc	2021-02-09	1,200	0.67	804
ETNB	89bio Inc	2023-07-17	0	9.21	0

Holding Weightings of Kathleen Laporte

Kathleen Laporte Form 4 Trading Tracker

According to the SEC Form 4 filings, Kathleen Laporte has made a total of 1 transactions in Bolt Biotherapeutics Inc (BOLT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Bolt Biotherapeutics Inc is the acquisition of 1,200 shares on February 9, 2021, which cost Kathleen Laporte around $24,000.

According to the SEC Form 4 filings, Kathleen Laporte has made a total of 1 transactions in 89bio Inc (ETNB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in 89bio Inc is the sale of 12,500 shares on July 17, 2023, which brought Kathleen Laporte around $235,000.

Insider Trading History of Kathleen Laporte

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kathleen Laporte Trading Performance

GuruFocus tracks the stock performance after each of Kathleen Laporte's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kathleen Laporte is -32.6%. GuruFocus also compares Kathleen Laporte's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kathleen Laporte within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kathleen Laporte's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kathleen Laporte

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	5.28
Relative Return to S&P 500(%)	6.2

Kathleen Laporte Ownership Network

Ownership Network List of Kathleen Laporte

No Data

Ownership Network Relation of Kathleen Laporte

Kathleen Laporte Owned Company Details

What does Precipio Inc do?

Who are the key executives at Precipio Inc?

Kathleen Laporte is the director of Precipio Inc. Other key executives at Precipio Inc include Chief Operations Officer Ahmed Zaki Sabet , director & Chief Executive Officer Ilan Danieli , and Chief Financial Officer Matthew Gage .

Precipio Inc (PRPO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Precipio Inc (PRPO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Precipio Inc (PRPO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Precipio Inc (PRPO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Precipio Inc Insider Transactions

No Available Data

What does Affymax Inc do?

Who are the key executives at Affymax Inc?

Kathleen Laporte is the director of Affymax Inc. Other key executives at Affymax Inc include Chief Financial Officer Mark G Thompson , Chief Commercial Officer Jeffrey H Knapp , and Chief Financial Officer Herb Cross .

Affymax Inc (AFFY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Affymax Inc (AFFY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Affymax Inc (AFFY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Affymax Inc (AFFY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Affymax Inc Insider Transactions

No Available Data

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Kathleen Laporte is the director of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

Over the past 18 months, Kathleen Laporte made no insider transaction in Paratek Pharmaceuticals Inc (PRTK). Other recent insider transactions involving Paratek Pharmaceuticals Inc (PRTK) include a net sale of 48,967 shares made by Evan Loh , a net sale of 34,526 shares made by William M. Haskel , and a net sale of 31,250 shares made by Michael Bigham .

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 142,346 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 142,346 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

What does eHealth Inc do?

Who are the key executives at eHealth Inc?

Kathleen Laporte is the director of eHealth Inc. Other key executives at eHealth Inc include SVP & General Counsel & Secr. Gavin G. Galimi , SVP & Chief Financial Officer John J Stelben , and director & Chief Executive Officer Soistman Francis S Jr .

eHealth Inc (EHTH) Insider Trades Summary

Over the past 18 months, Kathleen Laporte made no insider transaction in eHealth Inc (EHTH). Other recent insider transactions involving eHealth Inc (EHTH) include a net purchase of 24,865 shares made by Gavin G. Galimi , a net purchase of 27,932 shares made by Dale B Wolf , and a net purchase of 50,000 shares made by Soistman Francis S Jr .

In summary, during the past 3 months, insiders sold 0 shares of eHealth Inc (EHTH) in total and bought 87,365 shares, with a net purchase of 87,365 shares. During the past 18 months, 0 shares of eHealth Inc (EHTH) were sold and 122,797 shares were bought by its insiders, resulting in a net purchase of 122,797 shares.

eHealth Inc (EHTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

eHealth Inc Insider Transactions

No Available Data

What does Bolt Biotherapeutics Inc do?

Who are the key executives at Bolt Biotherapeutics Inc?

Kathleen Laporte is the director of Bolt Biotherapeutics Inc. Other key executives at Bolt Biotherapeutics Inc include Chief Financial Officer William P. Quinn , 10 percent owner Vivo Capital Fund Viii, L.p. , and 10 percent owner Novo Holdings A/s .

Bolt Biotherapeutics Inc (BOLT) Insider Trades Summary

Over the past 18 months, Kathleen Laporte made no insider transaction in Bolt Biotherapeutics Inc (BOLT). Other recent insider transactions involving Bolt Biotherapeutics Inc (BOLT) include a net sale of 200,000 shares made by Edgar Engleman , a net sale of 89,454 shares made by Vivo Capital Fund Viii, L.p. , and a net purchase of 11,829 shares made by William P. Quinn .

In summary, during the past 3 months, insiders sold 0 shares of Bolt Biotherapeutics Inc (BOLT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 289,454 shares of Bolt Biotherapeutics Inc (BOLT) were sold and 11,829 shares were bought by its insiders, resulting in a net sale of 277,625 shares.

Bolt Biotherapeutics Inc (BOLT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bolt Biotherapeutics Inc Insider Transactions

No Available Data

What does 89bio Inc do?

Who are the key executives at 89bio Inc?

Kathleen Laporte is the director of 89bio Inc. Other key executives at 89bio Inc include See Remarks Quoc Le-nguyen , director & Chief Executive Officer Rohan Palekar , and director & 10 percent owner Ra Capital Healthcare Fund Lp .

89bio Inc (ETNB) Insider Trades Summary

Over the past 18 months, Kathleen Laporte made 1 insider transaction in 89bio Inc (ETNB) with a net sale of 12,500. Other recent insider transactions involving 89bio Inc (ETNB) include a net sale of 72,195 shares made by Rohan Palekar , a net sale of 41,638 shares made by Quoc Le-nguyen , and a net purchase of 1,350,000 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 27,955 shares of 89bio Inc (ETNB) in total and bought 0 shares, with a net sale of 27,955 shares. During the past 18 months, 132,583 shares of 89bio Inc (ETNB) were sold and 1,350,000 shares were bought by its insiders, resulting in a net purchase of 1,217,417 shares.

89bio Inc (ETNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

89bio Inc Insider Transactions

No Available Data

What does Phoenix Biotech Acquisition Corp do?

Who are the key executives at Phoenix Biotech Acquisition Corp?

Kathleen Laporte is the director of Phoenix Biotech Acquisition Corp. Other key executives at Phoenix Biotech Acquisition Corp include director & 10 percent owner & CEO and and Secretary Christopher B Ehrlich , President Douglas Fisher , and Chief Financial Officer Daniel E. Geffken .

Phoenix Biotech Acquisition Corp (PBAX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Phoenix Biotech Acquisition Corp (PBAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Phoenix Biotech Acquisition Corp (PBAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Phoenix Biotech Acquisition Corp (PBAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Phoenix Biotech Acquisition Corp Insider Transactions

No Available Data

Kathleen Laporte Mailing Address

Above is the net worth, insider trading, and ownership report for Kathleen Laporte. Currently GuruFocus does not have mailing address information for Kathleen Laporte.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.